Evaluable PatientsI was just looking some previous MD & A on the progress of evaluable patients. That seems to me a major concern. on the 30th March, 2023 MD & A we had 53 evaluable patients.
Check this link for their MD & A just over a year ago
https://theralase.com/wp-content/uploads/2023/08/MDA-Q123.pdf
After a full year, we have an evaluable patients at 63. At the same rate we are going to need 4 more years to reach 100 evaluable patients. RDW is talking about completing the clinical study by 2024 and possible commercialization by end 2026. I am hoping taking on Dr. Jewet as a consultant would allow TLT to step on the Gas a bit. I am hoping the during the next month AUA meeting and Advisory board meeting with all TLT principal investigators in the USA would get us some Tail wind and get it going in the right direction.
Just some wishfull thinking on a Lazy Sunday Afternoon.